Jeevasare Health Care

Cervical Cancer Awareness

CERVICAL CANCER AWARENESS

  • Dr. Lavanya Kiran
  • Sr. Consultant - OBGyn, Fertility, Minimal Invasive Surgeon (Lap-Robotic)
Blog

There are Nearly 6 LAKH NEW CASES of cervical cancer and around 3lakhs deaths occured in 2020 globally due to Cervical Cancer. Of these, India reported around 21% of the total cervical cases, as per the data.

Cervical cancer is nothing but a malignant tumour of the cervix, which is the lowermost part of the Uterus.

Here at JEEVASARE HEALTH CARE we are offering a comprehensive health care exclusively for all our lovely ladies which includes a Pap smear test (A Screening test which enables us to detect Cervical cancer well in advance).

JEEVASARE HEALTH CARE is rolling out the HPV Vaccine against cervical cancer for girls aged 9 to 14 years and adults as well.

Given that the cost has been a significant barrier to increasing HPV Vaccination coverage, JEEVASARE HEALTH CARE offers Vaccination at discounted price as we consider this as our social responsibility.

Cervical cancer, one of the leading causes of cancer-related mortality among women worldwide, is mainly caused by persistent human papillomavirus (HPV) infection.

Primary prevention includes vaccination to prevent cervical cancer. Evidence from both randomised trials and population-based studies shows that vaccination against HPV reduces the incidence of cervical pre-cancer.

THE WORLD HEALTH ORGANISATION

(WHO) has prequalified and widely licensed the bivalent (HPV 16/18), quadrivalent (HPV 6/11/16/18), and nonvalent (HPV 6/11/16/18/31/33/45/52/58) vaccines. Given that HPV 16 and 18 are responsible for the majority of cervical cancers worlwide, all available vaccinations offer protection against these virus types.

"DON'T LET CERVICAL CANCER STOP YOU"

WHO recommendations on HPV vaccination for cervical cancer. According to WHO recommendations, girls aged 9-14 years prior to sexual activity are the primary target population for HPV Vaccination in order to prevent cervical cancer.